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Background
Visceral leishmaniasis is an infecto-parasitarian disease
caused by obligatory intracellular protozoa belonging to
the genus Leishmania, and might be lethal since there is
no precocious diagnosis and proper treatment. Despite
the considerable effort, there is no effective and safe
vaccine for human use [1]. Genetically modified micro-
organisms are used industrially in general for production
of hormone, antibiotics and proteins. In the production
of heterologous molecules, both the expression and the
production step are important [2]. Therefore, the study
of cultivation conditions in bioreactor plays an impor-
tant role for the process viability of batch and fed-batch
[3]. Thus, the aim of this work was to study strategies
for production of the 503 antigen of Leishmania infan-
tum chagasi using cultivation in batch and fed-batch.
Methods
The strain of E. coli expressing 503 antigen of Leishma-
nia infantum chagasi was kindly provided by Dr. Mary
Wilson (University of Iowa, USA) [1]. The clone was
cultured in 2xTY medium supplemented with ampicillin
and kanamycin. The cultivations were carried out using
a bench bioreactor with a work volume of 1.5 L, at fre-
quency of agitation of 400 rpm and constant output
aeration of 1 vvm. The expression of the recombinant
protein was induced by the addition of lactose to the
cultivation medium at the final concentration of 10 g/L
[4]. Optimization of cultivation conditions of 503 anti-
gen was performed in batch and fed-batch. Then, assays
of the fractions were performed by Lowry method and
electrophoresis, Biomass concentration was monitored
by the dry weigh and the acetic acid concentration was
assayed by high-performance liquid chromatography.
Results and conclusions
Fed-batch culture is one of the most performed strategies
to reach high cell densities of E.coli and consequently high
recombinant protein productivities. It was observed that
to the cultivations in fed-batch, the agitation of 400 rpm
resulted increased the biomass of 2.5 g/L to 11 g/L. It was
observed the same behavior for the protein using both
batch and fed-batch (0.11 g/L). In the present study in the
both processes it was not observed the inhibitory effect in
the cellular growth as well as on the 503 protein expres-
sion. The highest acetic acid concentration was obtained
at the agitation speed of 400 rpm (0.2 g/L) that occurred
during the first two hours of cultivation. However, this
concentration was inferior to 0.9 g/L that according to [5]
have no inhibitory effect in the growth.
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